Cite
HARVARD Citation
Sands, B. et al. (n.d.). OP033 The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme. Journal of Crohn's and colitis. p. S023. [Online].